Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.

BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem, but clinicopathological studies have only assessed olfaction in moderate dementia or an average of 5 years before death. It is not known whether, in patients with mild dementia (MMSE score over 20)...

Full description

Bibliographic Details
Main Authors: Williams, S, Williams, J, Combrinck, M, Christie, S, Smith, A, Mcshane, R
Format: Journal article
Language:English
Published: 2009
_version_ 1826262942603018240
author Williams, S
Williams, J
Combrinck, M
Christie, S
Smith, A
Mcshane, R
author_facet Williams, S
Williams, J
Combrinck, M
Christie, S
Smith, A
Mcshane, R
author_sort Williams, S
collection OXFORD
description BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem, but clinicopathological studies have only assessed olfaction in moderate dementia or an average of 5 years before death. It is not known whether, in patients with mild dementia (MMSE score over 20), olfactory function is more impaired in Alzheimer disease (AD) than dementia with Lewy bodies (DLB). METHODS: Patients with mild DLB (n = 21), mild AD (n = 27), mild cognitive impairment (MCI) (n = 21) and controls (n = 47) were assessed using a 16-item olfactory identification test and an olfactory threshold test which used sticks impregnated with differing concentrations of butanol. RESULTS: Patients with mild DLB had impaired olfactory identification ability compared with those with mild AD or MCI, independent of age, cognitive function and sex. The sensitivity of a cutoff score of seven correct responses out of 16 was 0.81 for distinguishing mild DLB from mild AD (AUC 0.682). The specificity, positive predictive value and negative predictive value for the same cut-off score were 0.41, 0.48 and 0.73, respectively. The olfactory threshold was not different in the AD and DLB groups. CONCLUSIONS: Simple bedside tests of olfactory identification merit further examination for their potential to improve the identification of patients with DLB when used alongside existing criteria. They are insufficiently specific for use in screening.
first_indexed 2024-03-06T19:43:48Z
format Journal article
id oxford-uuid:21913199-ee07-4aa5-b2c5-b798a5682775
institution University of Oxford
language English
last_indexed 2024-03-06T19:43:48Z
publishDate 2009
record_format dspace
spelling oxford-uuid:21913199-ee07-4aa5-b2c5-b798a56827752022-03-26T11:34:12ZOlfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:21913199-ee07-4aa5-b2c5-b798a5682775EnglishSymplectic Elements at Oxford2009Williams, SWilliams, JCombrinck, MChristie, SSmith, AMcshane, R BACKGROUND: Dementia patients with anosmia are more likely to have Lewy body pathology at postmortem, but clinicopathological studies have only assessed olfaction in moderate dementia or an average of 5 years before death. It is not known whether, in patients with mild dementia (MMSE score over 20), olfactory function is more impaired in Alzheimer disease (AD) than dementia with Lewy bodies (DLB). METHODS: Patients with mild DLB (n = 21), mild AD (n = 27), mild cognitive impairment (MCI) (n = 21) and controls (n = 47) were assessed using a 16-item olfactory identification test and an olfactory threshold test which used sticks impregnated with differing concentrations of butanol. RESULTS: Patients with mild DLB had impaired olfactory identification ability compared with those with mild AD or MCI, independent of age, cognitive function and sex. The sensitivity of a cutoff score of seven correct responses out of 16 was 0.81 for distinguishing mild DLB from mild AD (AUC 0.682). The specificity, positive predictive value and negative predictive value for the same cut-off score were 0.41, 0.48 and 0.73, respectively. The olfactory threshold was not different in the AD and DLB groups. CONCLUSIONS: Simple bedside tests of olfactory identification merit further examination for their potential to improve the identification of patients with DLB when used alongside existing criteria. They are insufficiently specific for use in screening.
spellingShingle Williams, S
Williams, J
Combrinck, M
Christie, S
Smith, A
Mcshane, R
Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title_full Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title_fullStr Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title_full_unstemmed Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title_short Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease.
title_sort olfactory impairment is more marked in patients with mild dementia with lewy bodies than those with mild alzheimer disease
work_keys_str_mv AT williamss olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease
AT williamsj olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease
AT combrinckm olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease
AT christies olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease
AT smitha olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease
AT mcshaner olfactoryimpairmentismoremarkedinpatientswithmilddementiawithlewybodiesthanthosewithmildalzheimerdisease